Technology that will initiate future revolutionary changes in healthcare and the clinical laboratory

Journal of Clinical Laboratory Analysis

Volumn 13, Issue 2, 1999, Pages 49-52

  Nakamura, Robert M ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOTECHNOLOGY; CLINICAL LABORATORY; DIAGNOSTIC PROCEDURE; HEALTH CARE DELIVERY; INFORMATION SYSTEM; PHARMACOGENETICS;

BIOTECHNOLOGY; DELIVERY OF HEALTH CARE; INFORMATION SYSTEMS; LABORATORIES; LABORATORY TECHNIQUES AND PROCEDURES;

EID: 0033044395     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1999)13:2<49::AID-JCLA1>3.0.CO;2-Z     Document Type: Article

References (23)

1. Nakamura RM, Bylund DJ. Factors influencing change in the clinical immunology laboratory. Clin Chem 1994;40:2193-2204.
2. Nakamura RM. Impact of the healthcare revolution and the future role of the clinical immunology laboratory. In: Nakamura RM, Burek CL, Cook L, Folds JD, Sever JL, editors. Clinical diagnostic immunology: protocols in quality assurance and standardization. Boston: Blackwell Science; 1998. p 32-40.
3. Poste G. Molecular medicine and information-based targeted healthcare. Nat Biotechnol 1998;16:19-21.
4. Back JF. Predictive medicine in autoimmune diseases: from the identification of genetic predisposition and environmental influence to precocious immunotherapy. Clin Immunol Immunopathol 1994;72: 156-161.
5. Osterland CK. Laboratory diagnosis and monitoring in chronic systemic autoimmune diseases. Clin Chem 1994;40:2146-2153.
6. Drews J. Biotechnology's metamorphosis into a drug discovery industry. Nat Biotechnol 1998;16(Suppl):22-24.
7. Haseltine WA. The power of genomics to transform the biotechnology industry. Nat Biotechnol 1998;16(Suppl):25-27.
8. Pickering L. Sequencing the genome. Genetic Engineering News 1998(Oct.);18:18, 4, 51.
9. Saegusa A. Japan plans economic growth through biotechnology. Nat Biotechnol 1998;16:329-330.
10. Sainato D. Microchip devices refine future clinical analyzer. Clinical Laboratory News (AACC) 1998;24:22-23.
11. Dutton G. Miniaturization in genomic screening. Genetic Engineering News 1998(Sept.);18: 12, 29, 30, 34.
12. Zhang M. Martin KJ, Sheng S, Sager R. Expression genetics: a different approach to cancer diagnosis and prognosis. Trends in Biotechnology (TIBTECH) 998;16:66-71.
13. Vaughan TJ, Williams AJ, Pritchard K, et al. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat Biotechnol 1996;14:309-314.
14. Vaughan TJ, Osbourn JK, Tempest PR. Human antibodies by design. Nat Biotechnol 1998;16:535-539.
15. Fujii I, Fukuyama S, Iwabuchi Y, Tanimura, R. Evolving catalytic antibodies in a phage-displayed combinatorial library. Nat Biotechnol 1998;16:463-467.
16. Lee SC. Biotechnology for nanotechnology. TIBTECH 1998;16:239-40.
17. Davis SS. Biomedical applications of nanotechnology - implications for drug targeting and gene therapy. TIBTECH 1997;15:217-224.
18. Holzman D. Partnership formed to create new biochip. Genetic Engineering News 1998(Aug.)18:1, 8, 47.
19. Marshall A, Hodgson J. DNA chips: an array of possibilities. Nat Biotechnol 1998;16:27-31.
20. Schena M, Heller RA, Theriault TP, Konrad K, Lachenmeier E, Davis RW. Microassays: biotechnology's discovery platform for functional genomics. Trends in Biotechnology (TIBTECH) 1998;16:301-306.
21. Van Walraven C, Naylor CD. Do we know what inappropriate laboratory utilization is? JAMA 1998;280: 550-558.
22. Guyatt GH, Tugwell PX, Feeny DH, et al. A framework for clinical evaluation of diagnostic techniques. Can Med Assoc J 1986;134:587-594.
23. Sainato D. Pharmacogenetics - what role in patient care? Clinical Laboratory News (AACC) 1998(Oct.);24:24-25.